Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation
Among patients who had had successful catheter ablation for atrial fibrillation at least 1 year earlier and had risk factors for stroke, treatment with rivaroxaban did not result in a significantly lower incidence of a composite of stroke, systemic embolism, or new covert embolic stroke than treatment with aspirin. (Funded by Bayer and others; OCEAN ClinicalTrials.gov number, NCT02168829.).
Authors
- Marc W. Deyell (ORCID: https://orcid.org/0000-0001-8434-7076)
- Andrew C.T. Ha (ORCID: https://orcid.org/0000-0002-1275-7313)
- Dieter Nuyens (ORCID: https://orcid.org/0000-0001-9390-3273)
- Jeff S. Healey (ORCID: https://orcid.org/0000-0003-1216-7580)
- Eric Edward Smith (ORCID: https://orcid.org/0000-0003-3956-1668)
- Malte Kuniss (ORCID: https://orcid.org/0000-0002-1593-9657)
- Hein Heidbüchel (ORCID: https://orcid.org/0000-0001-9301-8127)
- David H. Birnie (ORCID: https://orcid.org/0000-0001-6495-1428)
- Leon Iden (ORCID: https://orcid.org/0000-0001-6012-9293)
- Gerhard Hindricks (ORCID: https://orcid.org/0000-0001-7610-1156)
- Guy Amit (ORCID: https://orcid.org/0000-0002-4404-0683)
- Yunhe Wang (ORCID: https://orcid.org/0000-0001-5296-7019)
- George A. Wells (ORCID: https://orcid.org/0000-0002-2289-9139)
- Charles Dussault
- Chenyang Jiang (ORCID: https://orcid.org/0000-0002-0199-3353)
- Prashanthan Sanders (ORCID: https://orcid.org/0000-0003-3803-8429)
- Atul Verma (ORCID: https://orcid.org/0000-0002-1020-9727)
- Bhavanesh Makanjee
- Paulus Kirchhof (ORCID: https://orcid.org/0000-0002-1881-0197)
- Mukul Sharma (ORCID: https://orcid.org/0000-0002-6119-342X)
- Paul Novak (ORCID: https://orcid.org/0000-0002-8792-7938)
- Rajeev K. Pathak
- Jean Champagne (ORCID: https://orcid.org/0000-0001-9861-9351)
- F. Russell Quinn
- Pieter Koopman (ORCID: https://orcid.org/0000-0002-6373-180X)
- Vidal Essebag (ORCID: https://orcid.org/0000-0003-0107-5197)
- Nikolaos Dagres (ORCID: https://orcid.org/0000-0003-0323-4956)
- Umjeet Jolly
- Michael D. Hill (ORCID: https://orcid.org/0000-0002-6269-1543)
Institutions
- Royal Adelaide Hospital (AU)
- University Health Network (CA)
- Université de Sherbrooke (CA)
- University of British Columbia (CA)
- University of Ottawa (CA)
- Universität Hamburg (DE)
- University of Calgary (CA)
- University of Toronto (CA)
- Justus-Liebig-Universität Gießen (DE)
- Scarborough Health Network (CA)
- Royal Jubilee Hospital (CA)
- McGill University Health Centre (CA)
- Centre Hospitalier Universitaire de Sherbrooke (CA)
- Sir Run Run Shaw Hospital (CN)
- St Mary's Hospital Centre (CA)
- Humboldt-Universität zu Berlin (DE)
- Antwerp University Hospital (BE)
- University Medical Center Hamburg-Eppendorf (DE)
- Hartcentrum Hasselt (BE)
- Institut universitaire de cardiologie et de pneumologie de Québec (CA)
- St. Paul's Hospital (CA)
- Ziekenhuis Oost-Limburg (BE)
- Segeberger Kliniken (DE)
- Libin Cardiovascular Institute of Alberta (CA)
- The University of Adelaide (AU)
- HAW Hamburg (DE)
- Zhejiang University (CN)
- Hamilton Health Sciences (CA)
- McMaster University (CA)
Publication Details
- Journal
- New England Journal of Medicine
- Published
- 2025-11-06
- DOI
- https://doi.org/10.1056/nejmoa2509688
- Citations
- 13
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 18.05
Funders
- University of Toronto
- Cumming School of Medicine, University of Calgary